glp-1 prescription Prescribing Is Rising — But Not Equally Across Populations This gentle GLP-1/GIP+B12 - Aulcare MD

This part of the guideline is silly because there is no way to risk stratify these patients using the stated risk factors

The overexpression of SGLT-2 was observed in pancreatic cancer cells (Scafoglio et al., 2015)

It is worth noting that the amount of GLP-1 stimulated by yerba mate is significantly lower than what would be achieved through pharmaceutical means such as GLP-1 agonists like semaglutide

Arrae claims that MB-1 is clinically proven. This sounds exciting, until you realize that the supplement itself has not been studied

For sponsors designing trials in this space, hypertension data is no longer a secondary endpoint footnote

I thought: Oh, this is what normal people must feel like when theyre just not wanting to eat all the time. Just before Christmas 2024, Anita came off the jabs as the 225 monthly cost was proving too expensive